CD4 and neoplasm: The high-risk group was more significantly associated with tumor-infiltrating immune cells, such as macrophages, neutrophils, and CD8+ T cells, but negatively associated with myeloid dendritic cells and CD4+ T cells, as verified using the Wilcoxon signed-rank test (Fig. 6A).